| 000 | 01669 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517180913.0 | ||
| 264 | 0 | _c20171129 | |
| 008 | 201711s 0 0 eng d | ||
| 022 | _a1521-0103 | ||
| 024 | 7 |
_a10.1124/jpet.117.240507 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhou, Qingyu | |
| 245 | 0 | 0 |
_aActivation of Focal Adhesion Kinase and Src Mediates Acquired Sorafenib Resistance in A549 Human Lung Adenocarcinoma Xenografts. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _c12 2017 |
||
| 300 |
_a428-443 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aA549 Cells |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aDasatinib _xpharmacology |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 |
_aFocal Adhesion Protein-Tyrosine Kinases _xbiosynthesis |
| 650 | 0 | 4 |
_aGenes, src _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xbiosynthesis |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 |
_aOncogene Protein v-akt _xbiosynthesis |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xpharmacology |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aGuo, Xiaofang | |
| 700 | 1 | _aChoksi, Riya | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 363 _gno. 3 _gp. 428-443 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/jpet.117.240507 _zAvailable from publisher's website |
| 999 |
_c27674335 _d27674335 |
||